Ever fancied running your own corrupt medical drugs business? This is the game for you.
The Radiation and Nuclear Countermeasures Program is preparing for the worst.
A new unaffordable drug is hardly better than an old unaffordable one.
Cancer drug prices are increasing 10 percent annually. That’s fucked.
Instead, drug companies are just ignoring potentially vital adverse event reports.
When the crisis hit, the public research sector went into overdrive.
How to "de-link" the development of lifesaving drugs from a disinterested marketplace.
Soon it will be a lot harder for drug companies to hide bad trial results, at least in the EU.
Because antibiotics are best used sparingly and actually cure people, drug companies lack a business case to find new ones.
A new study highlights the global rift in research spending between the developed and developing world.